Skip to main content

Market Overview

38 Stocks Moving In Friday's Mid-Day Session

Share:

Gainers

  • Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 29.2% to $5.93 after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000 share buyback and announced the implementation of a holding company reorganization.
  • Farmmi, Inc. (NASDAQ: FAMI) jumped 24.5% to $0.4456. Farmmi shares fell 55% on Thursday after the company priced its $42.0 million upsized underwritten public offering of ordinary shares..
  • Remark Holdings, Inc. (NASDAQ: MARK) shares jumped 20.7% to $2.4501.
  • Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 20% to $41.03 after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired license for mRNA technology platform of Factor Bioscience Limited And Novellus Therapeutics Limited.
  • Mesoblast Limited (NASDAQ: MESO) gained 17.5% to $8.48 after the company announced 60-day results from the randomized controlled trial of remestemcel-L in COVID-19 patients with moderate/severe acute respiratory distress syndrome (ARDS), which had been halted after the third interim analysis, as previously announced.
  • Bel Fuse Inc. (NASDAQ: BELFB) surged 16.5% to $19.02.
  • CryoLife, Inc. (NYSE: CRY) gained 15% to $26.99 after the company reported better-than-expected Q1 results. Needham maintained Cryolife with a Buy and raised the price target from $33 to $38.
  • Naked Brand Group Limited (NASDAQ: NAKD) rose 14.6% to $0.7222. Naked Brand received NASDAQ notice of minimum bid price non-compliance.
  • Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) gained 12.6% to $34.40. Arcutis Biotherapeutics, last week, announced the presentation of new safety and efficacy data of roflumilast foam to treat scalp and body psoriasis.
  • Laureate Education, Inc. (NASDAQ: LAUR) surged 12.5% to $13.35 after the company announced it was notified the DOJ filed a Notice of Election to Decline Intervention with respect to a civil qui tam action filed by third-party relators against Walden University and the company.
  • 22nd Century Group, Inc. (NYSE: XXII) jumped 11.9% to $5.30 after dropping over 15% on Thursday.
  • Marathon Digital Holdings, Inc. (NASDAQ: MARA) gained 11.7% to $38.29 amid an increase in the price of bitcoin.
  • Airgain, Inc. (NASDAQ: AIRG) gained 9.6% to $23.58.
  • Five9, Inc. (NASDAQ: FIVN) rose 9.3% to $190.49 after the company reported better-than-expected Q1 results and raised FY21 guidance.
  • Ampco-Pittsburgh Corporation (NYSE: AP) gained 9.3% to $7.43.
  • Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares rose 8.4% to $7.71 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $17 price target.
  • BioNTech SE (NASDAQ: BNTX) surged 7.2% to $192.65 after the company, along with Pfizer, announced it has submitted a request to expand conditional marketing authorization of COMIRNATY in the European Union to adolescents.
  • Vaxart, Inc. (NASDAQ: VXRT) rose 7% to $9.85 after gaining over 9% on Thursday.
  • eHealth, Inc. (NASDAQ: EHTH) shares rose 4.7% to $73.47 after the company reported better-than-expected Q1 results.

Check out these big penny stock gainers and losers

Losers

  • NeoPhotonics Corporation (NASDAQ: NPTN) shares dipped 17.4% to $9.25 after the company issued weak forecast for the second quarter.
  • Cirrus Logic, Inc. (NASDAQ: CRUS) fell 16.7% to $71.82 after the company reported weaker-than-expected Q4 results and issued downbeat Q1 sales guidance.
  • MicroVision, Inc. (NASDAQ: MVIS) shares dropped 14.8% to $15.34 after the company reported worse-than-expected Q1 results.
  • Pitney Bowes Inc. (NYSE: PBI) fell 13.8% to $7.53 following Q1 results.
  • Twitter, Inc. (NYSE: TWTR) dropped 12.9% to $56.70. Twitter reported upbeat earnings for its first quarter, but issued weak revenue guidance for the second quarter.
  • Pacific Biosciences of California, Inc. (NASDAQ: PACB) shares declined 12.8% to $29.18 after the company reported its Q1 earnings results.
  • Ardelyx, Inc. (NASDAQ: ARDX) shares fell 12.3% to $7.39 after the company announced the PDUFA date for tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis has been extended by three months.
  • JMP Group LLC (NYSE: JMP) fell 11.9% to $5.57 after the company reported results for its first quarter.
  • U.S. Silica Holdings, Inc. (NYSE: SLCA) dropped 11.8% to $12.14 after the company reported Q1 results.
  • Palisade Bio, Inc. (NASDAQ: PALI) dipped 10.8% to $6.96 after dropping 24% on Thursday.
  • First Solar, Inc. (NASDAQ: FSLR) fell 9.9% to $78.63 after the company late Thursday reported worse-than-expected Q1 earnings.
  • ALX Oncology Holdings Inc. (NASDAQ: ALXO) dropped 9.9% to $64.54.
  • Limelight Networks, Inc. (NASDAQ: LLNW) fell 9.3% to $3.29 after the company reported worse-than-expected
  • Q1 results.
  • National Instruments Corporation (NASDAQ: NATI) dropped 9.2% to $41.56 after the company reported downbeat
  • Q1 sales and issued weak Q2 sales forecast.
  • Barclays PLC (NYSE: BCS) fell 9.1% to $9.71 following Q1 results.
  • Skyworks Solutions, Inc. (NASDAQ: SWKS) fell 8.3% to $181.39 after the company reported Q2 earnings and issued Q3 guidance.
  • WISeKey International Holding AG (NASDAQ: WKEY) fell 8% to $8.98 after the company reported FY 2020 audited consolidated financial results.
  • CPS Technologies Corporation (NASDAQ: CPSH) fell 7.6% to $7.43 after the company reported a decline in quarterly sales.
  • DexCom, Inc. (NASDAQ: DXCM) fell 6.6% to $393.92 after the company reported Q1 earnings results.
 

Related Articles (AIRG + ALXO)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Penny Stocks Small Cap Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com